Altria Group Plans to Sell 35 Million Shares of AB InBev

Business by 2FIRSTS.ai
Mar.15.2024
Altria Group Plans to Sell 35 Million Shares of AB InBev
Altria Group plans to sell 35 million shares of Anheuser-Busch InBev for $2.26 billion, reducing its stake to 10%.

According to Reuters on March 14th, Altria Group plans to sell 35 million shares of Anheuser-Busch InBev. Altria currently owns approximately 197 million shares of Anheuser-Busch InBev, representing a 10% stake in the company.

 

On the recent stock market closing day, the total value of this equity sale was $2.26 billion. Anheuser-Busch InBev plans to sell a portion of its American depositary shares of Budweiser in the United States, as well as conduct a private placement in the European Economic Area and the United Kingdom.

 

Altria Group announced that Anheuser-Busch InBev has agreed to repurchase $2 billion worth of common stock directly from Altria after the equity offering concludes.

 

Altria Group owns several tobacco brands including Marlboro and the vape company NJOY, while Anheuser-Busch InBev is one of the largest beer producers in the world, headquartered in Belgium. It was formed by the merger of Anheuser-Busch and InBev in 2008. The company operates multiple well-known beer brands such as Budweiser, Corona, Stella Artois, and Hoegaarden. Anheuser-Busch InBev holds a significant market share globally and continues to expand its business operations.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA CTP Acting Director  Supports Expanding Authorized Flavored E-Cigs and Legal Marketplace
FDA CTP Acting Director Supports Expanding Authorized Flavored E-Cigs and Legal Marketplace
At the FDLI Tobacco and Nicotine Policy Conference, FDA CTP Acting Director Bret Koplow spoke in favor of promoting tobacco harm reduction to reduce smoking. He backed a legal marketplace for authorized reduced-risk products, potential expansion of flavored e-cigs, and faster FDA reviews to ensure a strong, regulated market.
Oct.29 by 2FIRSTS.ai
Juul Wins UK Court Injunction, Ending Five-Year Legal Battle Against Chinese Vape Infringers
Juul Wins UK Court Injunction, Ending Five-Year Legal Battle Against Chinese Vape Infringers
The UK High Court has granted U.S. e-cigarette manufacturer Juul Labs a permanent injunction against four Chinese companies, bringing an end to a five-year patent and trademark infringement case. The defendants — Greensun Technology, Ouch, Gaish, and Airsmo Tech — failed to respond to any court communications or legal filings.
Oct.30 by 2FIRSTS.ai
AG Miyares Argues Vape Ban Consistent with Federal Law, Seeks Dismissal
AG Miyares Argues Vape Ban Consistent with Federal Law, Seeks Dismissal
Virginia Attorney General Jason Miyares and Tax Commissioner James J. Alex have asked a federal court to dismiss a lawsuit challenging the state’s ban on flavored e-cigarettes. They argue plaintiffs lack standing because the products are already illegal under federal law. The state denies claims of federal preemption and asserts sovereign immunity, maintaining that its ban aligns with its authority to protect public health.
Nov.24 by 2FIRSTS.ai
Uruguay Weighs Ban on Nicotine Pouches as Health Ministry Warns of Growing Use
Uruguay Weighs Ban on Nicotine Pouches as Health Ministry Warns of Growing Use
Nicotine pouches, promoted as flavored, smoke-free alternatives, are spreading in Uruguay despite the absence of a formal market. The Ministry of Public Health is considering banning them by decree and has raised the issue within Mercosur and at COP11. Health Minister Cristina Lustemberg warns that the industry is pushing new nicotine products to normalize consumption among youth.
Nov.20 by 2FIRSTS.ai
Imperial Brands Urges Retailers to Engage in Government Consultation on Tobacco and Vapes Bill
Imperial Brands Urges Retailers to Engage in Government Consultation on Tobacco and Vapes Bill
Imperial Brands is calling on UK retailers to take part in the Government’s consultation on the Tobacco and Vapes Bill, which will shape a new licensing framework for nicotine product sales across England, Wales and Northern Ireland. The Department of Health and Social Care’s call for evidence closes on 3 December 2025. Imperial Brands stresses this is a key chance for retailers to influence policy, support fair competition, and help curb illicit sales.
Nov.04
Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement
Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement
President Donald Trump signed the Continuing Appropriations Act, 2026 (H.R.5371) on November 12, Section 772 of Part B—the Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act (S.2256)—requires the FDA to allocate no less than $200 million in tobacco user fees to enforce regulations against illegal e-cigarettes, vapes, and other ENDS products. At least $2 million of this funding supports a federal multi-agency task force targeting products originating from the China.
Nov.14 by 2FIRSTS.ai